PATENT CLAIM ANALYSIS

Application Number: 16063558
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to a method for detecting miRNA-206 for analyzing the diagnosis or prognosis of a mental illness by a mood disorder, a method for providing information for the diagnosis, and a composition for targeting miRNA-206, more specifically, the present invention can detect diagnosis or prognostic analysis marker of the said mental illness by a mood disorder, enable a more accurate diagnosis of a mental illness by a mood disorder by measuring the expression level of miR-206 from a tissue sample of a patient, provide a diagnostic composition capable of measuring the expression level of the said miR-206, and furthermore provide a pharmaceutical composition capable of treating and preventing a mental illness by a mood disorder by using an oligonucleotide that can bind complementary to microRNA-206.

Claim (Index 13):
The pharmaceutical composition for treating or preventing a mental illness by a mood disorder according to  claim 12 , wherein the substance targeting the said miR-206 comprises a nucleic acid molecule capable of binding to all or part of the nucleotide sequence of SEQ ID NO: 1 of the said miR-206.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 2.26667
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13525657', '13581032', '15002107', '15111539', '14236928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7559961277068398
- 35 USC 102 Novelty (BERT): 0.5016243550513977
- Combined Prediction Score: 0.7305589504412956
- Mean Citation Score: 187.938438
- Max Citation Score: 193.34976
- Similarity Product: 118.68809543289184

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test